{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:11:53Z","timestamp":1768713113118,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Institute for Maternal and Child Health -- IRCCS \u201cBurlo Garofolo\u201d","award":["RC 44\/22"],"award-info":[{"award-number":["RC 44\/22"]}]},{"name":"Institute for Maternal and Child Health -- IRCCS \u201cBurlo Garofolo\u201d","award":["RC 07\/14"],"award-info":[{"award-number":["RC 07\/14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-024-04068-6","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T18:26:34Z","timestamp":1734546394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Time-efficient strategies in human iPS cell-derived pancreatic progenitor differentiation and cryopreservation: advancing towards practical applications"],"prefix":"10.1186","volume":"15","author":[{"given":"Elena","family":"Genova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Rispoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Fengming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johkura","family":"Kohei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Bramuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Bulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Lucaf\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalba Monica","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Decorti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Stocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"4","key":"4068_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"1680","key":"4068_CR2","doi-asserted-by":"publisher","first-page":"20140367","DOI":"10.1098\/rstb.2014.0367","volume":"370","author":"M Ohnuki","year":"2015","unstructured":"Ohnuki M, Takahashi K. Present and future challenges of induced pluripotent stem cells. Philos Trans R Soc Lond B Biol Sci. 2015;370(1680):20140367.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"4068_CR3","doi-asserted-by":"publisher","first-page":"e1630","DOI":"10.1002\/wsbm.1630","volume":"16","author":"P Rispoli","year":"2024","unstructured":"Rispoli P, Scandiuzzi Piovesan T, Decorti G, Stocco G, Lucaf\u00f2 M. iPSCs as a groundbreaking tool for the study of adverse drug reactions: a new avenue for personalized therapy. WIREs Mech Dis. 2024;16(1):e1630.","journal-title":"WIREs Mech Dis"},{"issue":"1","key":"4068_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cell.2009.03.034","volume":"137","author":"S Yamanaka","year":"2009","unstructured":"Yamanaka S. A fresh look at iPS cells. Cell. 2009;137(1):13\u20137.","journal-title":"Cell"},{"issue":"12","key":"4068_CR5","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.4252\/wjsc.v11.i12.1020","volume":"11","author":"E Genova","year":"2019","unstructured":"Genova E, Cavion F, Lucaf\u00f2 M, Leo LD, Pelin M, Stocco G, et al. Induced pluripotent stem cells for therapy personalization in pediatric patients: focus on drug-induced adverse events. World J Stem Cells. 2019;11(12):1020\u201344.","journal-title":"World J Stem Cells"},{"issue":"3","key":"4068_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00441-013-1695-6","volume":"354","author":"S Takizawa-Shirasawa","year":"2013","unstructured":"Takizawa-Shirasawa S, Yoshie S, Yue F, Mogi A, Yokoyama T, Tomotsune D, et al. FGF7 and cell density are required for final differentiation of pancreatic amylase-positive cells from human ES cells. Cell Tissue Res. 2013;354(3):751\u20139.","journal-title":"Cell Tissue Res"},{"issue":"35","key":"4068_CR7","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.3748\/wjg.v27.i35.5796","volume":"27","author":"E Genova","year":"2021","unstructured":"Genova E, Stocco G, Decorti G. Induced pluripotent stem cells as an innovative model to study drug induced pancreatitis. World J Gastroenterol. 2021;27(35):5796\u2013802.","journal-title":"World J Gastroenterol"},{"key":"4068_CR8","doi-asserted-by":"publisher","first-page":"101548","DOI":"10.1016\/j.scr.2019.101548","volume":"40","author":"G Lanzi","year":"2019","unstructured":"Lanzi G, Masneri S, Ferraro RM, Genova E, Piovani G, Barisani C, et al. Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn\u2019s disease. Stem Cell Res. 2019;40:101548.","journal-title":"Stem Cell Res"},{"key":"4068_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-4939-4011-0_5","volume":"1465","author":"N DeSouza","year":"2016","unstructured":"DeSouza N, Zhou M, Shan Y. Cell cycle analysis of CML Stem cells using Hoechst 33342 and Propidium Iodide. Methods Mol Biol Clifton NJ. 2016;1465:47\u201357.","journal-title":"Methods Mol Biol Clifton NJ"},{"issue":"9","key":"4068_CR10","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3390\/cells10092319","volume":"10","author":"MAM Aboul-Soud","year":"2021","unstructured":"Aboul-Soud MAM, Alzahrani AJ, Mahmoud A. Induced Pluripotent Stem cells (iPSCs)-Roles in Regenerative therapies, Disease Modelling and Drug Screening. Cells. 2021;10(9):2319.","journal-title":"Cells"},{"key":"4068_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/5584_2018_290","volume":"1144","author":"B Talug","year":"2019","unstructured":"Talug B, Tokcaer-Keskin Z. Induced Pluripotent Stem cells in Disease Modelling and Regeneration. Adv Exp Med Biol. 2019;1144:91\u20139.","journal-title":"Adv Exp Med Biol"},{"key":"4068_CR12","unstructured":"Rispoli P, Scandiuzzi Piovesan T, Decorti G, Stocco G, Lucaf\u00f2 M. A closer look at Induced Pluripotent Stem cells: IPSCS as an innovative Tool for adverse drug reactions Assessment and Therapy personalization. Advances in Health and Disease. Lowell T. Duncan; 2023. pp. 213\u2013301."},{"key":"4068_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/B978-0-12-386033-0.00004-9","volume":"292","author":"ES Philonenko","year":"2011","unstructured":"Philonenko ES, Shutova MV, Chestkov IV, Lagarkova MA, Kiselev SL. Current progress and potential practical application for human pluripotent stem cells. Int Rev Cell Mol Biol. 2011;292:153\u201396.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"4","key":"4068_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1161\/CIRCRESAHA.118.312913","volume":"123","author":"DT Paik","year":"2018","unstructured":"Paik DT, Tian L, Lee J, Sayed N, Chen IY, Rhee S, et al. Large-scale single-cell RNA-Seq reveals Molecular signatures of heterogeneous populations of Human Induced Pluripotent Stem cell-derived endothelial cells. Circ Res. 2018;123(4):443\u201350.","journal-title":"Circ Res"},{"issue":"4","key":"4068_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1165\/rcmb.2020-0259OC","volume":"65","author":"YL Sun","year":"2021","unstructured":"Sun YL, Hurley K, Villacorta-Martin C, Huang J, Hinds A, Gopalan K, et al. Heterogeneity in Human Induced Pluripotent Stem Cell-derived alveolar epithelial type II cells revealed with ABCA3\/SFTPC reporters. Am J Respir Cell Mol Biol. 2021;65(4):442\u201360.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"4068_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/MOH.0000000000000140","volume":"22","author":"MC Yoder","year":"2015","unstructured":"Yoder MC. Differentiation of pluripotent stem cells into endothelial cells. Curr Opin Hematol. 2015;22(3):252.","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"4068_CR17","doi-asserted-by":"publisher","first-page":"17504","DOI":"10.1038\/s41598-017-17882-1","volume":"7","author":"HE Marei","year":"2017","unstructured":"Marei HE, Althani A, Lashen S, Cenciarelli C, Hasan A. Genetically unmatched human iPSC and ESC exhibit equivalent gene expression and neuronal differentiation potential. Sci Rep. 2017;7(1):17504.","journal-title":"Sci Rep"},{"key":"4068_CR18","doi-asserted-by":"publisher","first-page":"111459","DOI":"10.1016\/j.mce.2021.111459","volume":"538","author":"ME Alvarez Fallas","year":"2021","unstructured":"Alvarez Fallas ME, Pedraza-Arevalo S, Cujba AM, Manea T, Lambert C, Morrugares R, et al. Stem\/progenitor cells in normal physiology and disease of the pancreas. Mol Cell Endocrinol. 2021;538:111459.","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"4068_CR19","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrg841","volume":"3","author":"H Edlund","year":"2002","unstructured":"Edlund H. Pancreatic organogenesis\u2013developmental mechanisms and implications for therapy. Nat Rev Genet. 2002;3(7):524\u201332.","journal-title":"Nat Rev Genet"},{"key":"4068_CR20","doi-asserted-by":"publisher","first-page":"9301382","DOI":"10.1155\/2019\/9301382","volume":"2019","author":"M Hohwieler","year":"2019","unstructured":"Hohwieler M, M\u00fcller M, Frappart PO, Heller S. Pancreatic progenitors and organoids as a prerequisite to Model Pancreatic diseases and Cancer. Stem Cells Int. 2019;2019:9301382.","journal-title":"Stem Cells Int"},{"issue":"10","key":"4068_CR21","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1007\/s00125-020-05161-0","volume":"63","author":"RE Jennings","year":"2020","unstructured":"Jennings RE, Scharfmann R, Staels W. Transcription factors that shape the mammalian pancreas. Diabetologia. 2020;63(10):1974\u201380.","journal-title":"Diabetologia"},{"issue":"11","key":"4068_CR22","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1101\/gad.1412806","volume":"20","author":"T Miyatsuka","year":"2006","unstructured":"Miyatsuka T, Kaneto H, Shiraiwa T, Matsuoka T, aki, Yamamoto K, Kato K, et al. Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev. 2006;20(11):1435\u201340.","journal-title":"Genes Dev"},{"issue":"11","key":"4068_CR23","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1210\/endo.140.11.7122","volume":"140","author":"DA Stoffers","year":"1999","unstructured":"Stoffers DA, Heller RS, Miller CP, Habener JF. Developmental expression of the homeodomain protein IDX-1 in mice transgenic for an IDX-1 promoter\/lacZ transcriptional reporter. Endocrinology. 1999;140(11):5374\u201381.","journal-title":"Endocrinology"},{"issue":"8","key":"4068_CR24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jcyt.2013.03.006","volume":"15","author":"Q Liu","year":"2013","unstructured":"Liu Q, Pedersen OZ, Peng J, Couture LA, Rao MS, Zeng X. Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantation. Cytotherapy. 2013;15(8):999\u20131010.","journal-title":"Cytotherapy"},{"issue":"7","key":"4068_CR25","doi-asserted-by":"publisher","first-page":"e6233","DOI":"10.1371\/journal.pone.0006233","volume":"4","author":"A Swistowski","year":"2009","unstructured":"Swistowski A, Peng J, Han Y, Swistowska AM, Rao MS, Zeng X. Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS ONE. 2009;4(7):e6233.","journal-title":"PLoS ONE"},{"issue":"10","key":"4068_CR26","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/stem.499","volume":"28","author":"A Swistowski","year":"2010","unstructured":"Swistowski A, Peng J, Liu Q, Mali P, Rao MS, Cheng L, et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells Dayt Ohio. 2010;28(10):1893\u2013904.","journal-title":"Stem Cells Dayt Ohio"},{"issue":"5","key":"4068_CR27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/cells12050682","volume":"12","author":"S Weiskirchen","year":"2023","unstructured":"Weiskirchen S, Schr\u00f6der SK, Buhl EM, Weiskirchen R. A beginner\u2019s guide to Cell Culture: practical advice for preventing needless problems. Cells. 2023;12(5):682.","journal-title":"Cells"},{"key":"4068_CR28","doi-asserted-by":"crossref","unstructured":"Aze A, Maiorano D. Recent advances in understanding DNA replication: cell type-specific adaptation of the DNA replication program. F1000Research. 2018;7:F1000 Faculty Rev-1351.","DOI":"10.12688\/f1000research.15408.1"},{"issue":"1","key":"4068_CR29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41598-018-36606-7","volume":"9","author":"S Konagaya","year":"2019","unstructured":"Konagaya S, Iwata H. Chemically defined conditions for long-term maintenance of pancreatic progenitors derived from human induced pluripotent stem cells. Sci Rep. 2019;9(1):640.","journal-title":"Sci Rep"},{"issue":"5","key":"4068_CR30","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.stemcr.2022.03.013","volume":"17","author":"A Nakamura","year":"2022","unstructured":"Nakamura A, Wong YF, Venturato A, Michaut M, Venkateswaran S, Santra M, et al. Long-term feeder-free culture of human pancreatic progenitors on fibronectin or matrix-free polymer potentiates \u03b2 cell differentiation. Stem Cell Rep. 2022;17(5):1215\u201328.","journal-title":"Stem Cell Rep"},{"issue":"6","key":"4068_CR31","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.devcel.2010.05.015","volume":"18","author":"AE Schaffer","year":"2010","unstructured":"Schaffer AE, Freude KK, Nelson SB, Sander M. Nkx6 transcription factors and Ptf1a function as antagonistic lineage determinants in multipotent pancreatic progenitors. Dev Cell. 2010;18(6):1022\u20139.","journal-title":"Dev Cell"},{"key":"4068_CR32","doi-asserted-by":"crossref","unstructured":"Fc SA, Xp B. W. PDX-1 and the pancreas. Pancreas [Internet]. 2004 Mar [cited 2024 Oct 6];28(2). https:\/\/pubmed.ncbi.nlm.nih.gov\/15028942\/","DOI":"10.1097\/00006676-200403000-00001"},{"key":"4068_CR33","doi-asserted-by":"publisher","first-page":"1091757","DOI":"10.3389\/fmolb.2022.1091757","volume":"9","author":"N Ebrahim","year":"2022","unstructured":"Ebrahim N, Shakirova K, Dashinimaev E. PDX1 is the cornerstone of pancreatic \u03b2-cell functions and identity. Front Mol Biosci. 2022;9:1091757.","journal-title":"Front Mol Biosci"},{"key":"4068_CR34","doi-asserted-by":"publisher","first-page":"298163","DOI":"10.1155\/2014\/298163","volume":"2014","author":"A Kallas","year":"2014","unstructured":"Kallas A, Pook M, Trei A, Maimets T. SOX2 is regulated differently from NANOG and OCT4 in human embryonic stem cells during early differentiation initiated with Sodium Butyrate. Stem Cells Int. 2014;2014:298163.","journal-title":"Stem Cells Int"},{"issue":"9","key":"4068_CR35","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.stemcr.2021.07.021","volume":"16","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Chen C, Randolph LN, Ye S, Zhang X, Bao X, et al. Generation of pancreatic progenitors from human pluripotent stem cells by small molecules. Stem Cell Rep. 2021;16(9):2395\u2013409.","journal-title":"Stem Cell Rep"},{"issue":"3","key":"4068_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.tiv.2005.06.043","volume":"20","author":"S Adler","year":"2006","unstructured":"Adler S, Pellizzer C, Paparella M, Hartung T, Bremer S. The effects of solvents on embryonic stem cell differentiation. Toxicol Vitro Int J Publ Assoc BIBRA. 2006;20(3):265\u201371.","journal-title":"Toxicol Vitro Int J Publ Assoc BIBRA"},{"issue":"6","key":"4068_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nmeth.2442","volume":"10","author":"S Chetty","year":"2013","unstructured":"Chetty S, Pagliuca FW, Honore C, Kweudjeu A, Rezania A, Melton DA. A simple tool to improve pluripotent stem cell differentiation. Nat Methods. 2013;10(6):553\u20136.","journal-title":"Nat Methods"},{"issue":"2","key":"4068_CR38","doi-asserted-by":"publisher","first-page":"e0117689","DOI":"10.1371\/journal.pone.0117689","volume":"10","author":"K Czysz","year":"2015","unstructured":"Czysz K, Minger S, Thomas N. DMSO efficiently down regulates pluripotency genes in human embryonic stem cells during definitive endoderm derivation and increases the proficiency of hepatic differentiation. PLoS ONE. 2015;10(2):e0117689.","journal-title":"PLoS ONE"},{"key":"4068_CR39","doi-asserted-by":"publisher","first-page":"8835353","DOI":"10.1155\/2020\/8835353","volume":"2020","author":"MI Sousa","year":"2020","unstructured":"Sousa MI, Correia B, Branco AF, Rodrigues AS, Ramalho-Santos J. Effects of DMSO on the pluripotency of cultured mouse embryonic stem cells (mESCs). Stem Cells Int. 2020;2020:8835353.","journal-title":"Stem Cells Int"},{"issue":"6","key":"4068_CR40","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.stemcr.2017.05.019","volume":"8","author":"J Trott","year":"2017","unstructured":"Trott J, Tan EK, Ong S, Titmarsh DM, Denil SLIJ, Giam M, et al. Long-term culture of self-renewing pancreatic progenitors derived from human pluripotent stem cells. Stem Cell Rep. 2017;8(6):1675\u201388.","journal-title":"Stem Cell Rep"},{"key":"4068_CR41","doi-asserted-by":"crossref","unstructured":"S DM, Q W, F TJS. Z, Y X, Culturing and transcriptome profiling of progenitor-like colonies derived from adult mouse pancreas. Stem Cell Res Ther [Internet]. 2017 Jul 26 [cited 2024 Oct 6];8(1). https:\/\/pubmed.ncbi.nlm.nih.gov\/28747214\/","DOI":"10.1186\/s13287-017-0626-y"},{"issue":"11","key":"4068_CR42","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1016\/j.celrep.2016.11.051","volume":"17","author":"NJ Wewer Albrechtsen","year":"2016","unstructured":"Wewer Albrechtsen NJ, Albrechtsen R, Bremholm L, Svendsen B, Kuhre RE, Poulsen SS, et al. Glucagon-like peptide 1 receptor signaling in Acinar cells causes growth-dependent release of pancreatic enzymes. Cell Rep. 2016;17(11):2845\u201356.","journal-title":"Cell Rep"},{"issue":"5","key":"4068_CR43","doi-asserted-by":"publisher","first-page":"e0285783","DOI":"10.1371\/journal.pone.0285783","volume":"18","author":"J Inui","year":"2023","unstructured":"Inui J, Ueyama-Toba Y, Mitani S, Mizuguchi H. Development of a method of passaging and freezing human iPS cell-derived hepatocytes to improve their functions. PLoS ONE. 2023;18(5):e0285783.","journal-title":"PLoS ONE"},{"key":"4068_CR44","doi-asserted-by":"crossref","unstructured":"Rj FC, Hy JKS, By L. H, A R, Broad Distribution of Hepatocyte Proliferation in Liver Homeostasis and Regeneration. Cell Stem Cell [Internet]. 2020 Feb 1 [cited 2024 Oct 6];26(1). https:\/\/pubmed.ncbi.nlm.nih.gov\/31866223\/","DOI":"10.1016\/j.stem.2019.11.001"},{"issue":"1","key":"4068_CR45","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1002\/cpsc.117","volume":"54","author":"T Rivera","year":"2020","unstructured":"Rivera T, Zhao Y, Ni Y, Wang J. Human-Induced Pluripotent Stem Cell Culture methods under cGMP conditions. Curr Protoc Stem Cell Biol. 2020;54(1):e117.","journal-title":"Curr Protoc Stem Cell Biol"},{"issue":"3","key":"4068_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2015.07.001","volume":"162","author":"KAU Gonzales","year":"2015","unstructured":"Gonzales KAU, Liang H, Lim YS, Chan YS, Yeo JC, Tan CP, et al. Deterministic restriction on pluripotent state dissolution by cell-cycle pathways. Cell. 2015;162(3):564\u201379.","journal-title":"Cell"},{"issue":"2","key":"4068_CR47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/cpt.1837","volume":"108","author":"E Genova","year":"2020","unstructured":"Genova E, Cavion F, Lucaf\u00f2 M, Pelin M, Lanzi G, Masneri S, et al. Biomarkers and Precision Therapy for primary immunodeficiencies: an in Vitro Study based on Induced Pluripotent stem cells from patients. Clin Pharmacol Ther. 2020;108(2):358\u201367.","journal-title":"Clin Pharmacol Ther"},{"key":"4068_CR48","first-page":"62","volume":"96","author":"A Mitchell","year":"2017","unstructured":"Mitchell A, Drinnan CT, Jensen T, Finck C. Production of high purity alveolar-like cells from iPSCs through depletion of uncommitted cells after AFE induction. Differ Res Biol Divers. 2017;96:62\u20139.","journal-title":"Differ Res Biol Divers"},{"issue":"3","key":"4068_CR49","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/cvr\/cvs185","volume":"95","author":"B Lin","year":"2012","unstructured":"Lin B, Kim J, Li Y, Pan H, Carvajal-Vergara X, Salama G, et al. High-purity enrichment of functional cardiovascular cells from human iPS cells. Cardiovasc Res. 2012;95(3):327.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"4068_CR50","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/cells8050403","volume":"8","author":"MX Doss","year":"2019","unstructured":"Doss MX, Sachinidis A. Current challenges of iPSC-Based Disease modeling and therapeutic implications. Cells. 2019;8(5):403.","journal-title":"Cells"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-04068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-04068-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-04068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T19:05:26Z","timestamp":1734548726000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-04068-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4068"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-04068-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of the Institute of Maternal and Child Health IRCCS Burlo Garofolo, with approval number 1556 (internal ID of the study RC 07\/14 and RC 44\/22). Title of the approved project: \u201c Patient-derived induced pluripotent stem cells for personalizing therapy: the paradigm of thiopurine pancreatitis in Crohn\u2019s disease\u201d and \u201cComparison of 2D and 3D patient-derived pancreatic exocrine models for the study of thiopurine induced pancreatitis in pediatric IBD patients: an innovative approach therapy personalization\u201d; Name of the institutional approval committee: Ethical Committee of the Institute of Maternal and Child Health IRCCS Burlo Garofolo (Trieste, Italy); Approval number: 1556; Date of approval: 14.07.2014.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"483"}}